Ikeda, M.; Koh, Y.; Teraoka, S.; Sato, K.; Oyanagi, J.; Hayata, A.; Tokudome, N.; Akamatsu, H.; Ozawa, Y.; Endo, K.;
et al. Longitudinal Evaluation of PD-L1 Expression on Circulating Tumor Cells in Non-Small Cell Lung Cancer Patients Treated with Nivolumab. Cancers 2021, 13, 2290.
https://doi.org/10.3390/cancers13102290
AMA Style
Ikeda M, Koh Y, Teraoka S, Sato K, Oyanagi J, Hayata A, Tokudome N, Akamatsu H, Ozawa Y, Endo K,
et al. Longitudinal Evaluation of PD-L1 Expression on Circulating Tumor Cells in Non-Small Cell Lung Cancer Patients Treated with Nivolumab. Cancers. 2021; 13(10):2290.
https://doi.org/10.3390/cancers13102290
Chicago/Turabian Style
Ikeda, Mio, Yasuhiro Koh, Shunsuke Teraoka, Koichi Sato, Jun Oyanagi, Atsushi Hayata, Nahomi Tokudome, Hiroaki Akamatsu, Yuichi Ozawa, Katsuya Endo,
and et al. 2021. "Longitudinal Evaluation of PD-L1 Expression on Circulating Tumor Cells in Non-Small Cell Lung Cancer Patients Treated with Nivolumab" Cancers 13, no. 10: 2290.
https://doi.org/10.3390/cancers13102290
APA Style
Ikeda, M., Koh, Y., Teraoka, S., Sato, K., Oyanagi, J., Hayata, A., Tokudome, N., Akamatsu, H., Ozawa, Y., Endo, K., Higuchi, M., Nakanishi, M., Ueda, H., & Yamamoto, N.
(2021). Longitudinal Evaluation of PD-L1 Expression on Circulating Tumor Cells in Non-Small Cell Lung Cancer Patients Treated with Nivolumab. Cancers, 13(10), 2290.
https://doi.org/10.3390/cancers13102290
